Hookipa Pharma Long Term Debt

Hookipa Pharma (HOOK) currently reports a long-term debt of $300K as of June 2025. That compares with $3.4M in the prior-year period — down 91.2% year over year. Use the charts on this page to explore Hookipa Pharma's long-term debt history and peer comparisons.

Hookipa Pharma's long-term debt decreased from $3.4M to $300K — a 91.2% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hookipa Pharma reported $300K in long-term debt as of June 2025. That compares with $3.4M in the prior-year period — down 91.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $300K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hookipa Pharma, and consider following HOOK for alerts when major investors trade the stock.

Hookipa Pharma is classified in the Healthcare sector. On long-term debt, it currently shows $300K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HOOK with unrelated industries.